Ivy Elkins
@ivybelkins
Co-Founder, @EGFRResisters LC Patient Group; writer for lungcancer.net; lc advocate/survivor; dx stage IV 2013, @Princeton & @Wharton alum.
ID: 793207603291500544
http://egfrcancer.org 31-10-2016 21:46:44
3,3K Tweet
5,5K Followers
3,3K Following
A few years back, Narjust Florez, MD, FASCO told me about an idea for a study on #sexualhealth in women with #lungcancer . Today, the paper is online! Congrats, team! Kelly Meza, MD, Ana I. Velázquez Mañana, MD, MSc, FASCO, Jill Feldman, Idalid "Ivy" Franco MD MPH, Ivy Elkins Jennifer C. King, PhD acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #LCSM
So excited to kick off November’s Lung Cancer Awareness Month with this announcement! We have now funded over $1 million in patient- directed research to improve outcomes for patients with #EGFR+ #lungcancer! #lcsm #lcam EGFR Resisters LUNGevity Foundation
A major milestone for the EGFR Resisters — our 5th annual EGFR Resisters Research Summit! Glad to be here this weekend to meet the young investigators who are the future of #lungcancer research. #lcsm #lcam
I’m excited to be at this year’s EGFR Resisters Research Summit with all of these rising stars! EGFR Resisters Research Summit EGFR Resisters
Such an exciting and rewarding opportunity to attend this year’s EGFR Resisters Research Summit! An overwhelming amount of exciting work presented by talented young physicians/scientists. And powerful talks by influential and eloquent patient advocates. 💪 EGFR Resisters
Congratulations to our Runner Up Junior Faculty winner, Alvaro Quintanal-Villalonga of Memorial Sloan Kettering Cancer Center! #EGFR #MedEd #MedX #MedTwitter #EGFRSummit
Congratulations to this year’s Distinguished Young Investigator, Benjamin Herzberg of Columbia Medicine and Herbert Irving Comprehensive Cancer Center! #EGFR #MedEd #MedX #MedTwitter EGFR Resisters #EGFRSummit
Congratulations to the EGFR Resisters Research Summit trainee award winners - Drs. Kevin Levine Marie Dreyer and Eric Gardner! Really great presentations all around!
This should not be happening, CVS Pharmacy! Nonsensical refill denials like this add to patient stress and waste valuable oncologist time! #lcsm #lcam #endpriorauth
Ivy Elkins does a good job of outlining the challenges of this therapy. Research has shown that patients would need a two year increase to accept... Patient Perspective: Patients With EGFR NSCLC May Still Opt for Quality Over Quantity After FLAURA2 ilcn.org/patient-perspe…
Improved efficacy with combination treatment is important, but not necessarily at the expense of quality of life. Ivy Elkins shares a patient perspective in #ILCN: bit.ly/3RfmkGP EGFR Resisters #LCSM
Honored to be part of this group! #lcsm EGFR Resisters
I’ve teamed up with J&J Innovative Medicine to educate and equip members of historically underrepresented communities impacted by #LungCancer to become online health advocates. Apply for the free BeLUNG Here Digital Advocacy Program so your voice can be heard: bit.ly/48drycy #Ad
Link to the webinar: Research Update: EGFR Resisters and Lung Cancer Research Foundation This webcast is an update on the three 2022 EGFR Resisters-funded research projects in collaboration with the Lung Cancer Research Foundation (LCRF) lcrf.zoom.us/rec/play/aOYZ-…
Our thematic analysis of #priorauth comments finds: Patients feel #priorauthorization is a confusing, opaque process that increases the administrative & psychosocial burdens of cancer care. 🏆Dr Bridgette Thom, PhD won a #APOS2024 Poster Award yesterday for this #fixpriorauth work.
